Phase
Preclinical & Translational
Once programs leave pure discovery, the demands change. Biology must withstand pressure. Evidence must connect molecular findings to real outcomes. This is where translational clarity sets the tone for the rest of the development.
What companies need at this stage
Teams aim to understand mechanisms, build predictive biomarkers, and design preclinical studies that can be translated. They need confidence that what works in model systems will hold true in human biology.
BioLizard solutions
- Deep multi-omics integration to unite transcriptomics, proteomics, metabolomics, and clinical annotations.
- Mechanism of action analysis through pathway, network, and causal tools.
- PK and PD biomarker frameworks that stand up in later phases.
- Animal to human translation models that preserve biological meaning.
- QC and validated workflows ready for IND packages.
Relevant Bio|Verse® modules
Bio|Mx® anchors translational insight. Dashboards let teams track biomarkers, explore mechanistic patterns, and compare preclinical and human data.
Explore →
Modular offerings
Multi-omics modeling | Digital twin simulations | Proteomics and metabolomics pipelines | IND and IMPD data structures
Explore all solutions →
Literature mining for benchmarking analysis
The Challenge The client is conducting a first-in-human trial of a treatment for osteoarthritis and needs to assess its performance against competing therapies and determine the appropriate sample size for the pivotal trial. There are too many articles to review...
Converting genetic resistance into metabolic yield
Salmonella infection in poultry has a detrimental effect on growth and therefore production. Knowledge of host resistance genes helps optimize precision management.
Omics-driven diagnostics in animals
Chronic diseases are a burden for companion animals, but can be managed better if diagnosed early. Multi-omics analysis is complex, but offers opportunities to discover novel biomarker panels.